Literature DB >> 32257757

Primary advanced pulmonary synovial sarcoma treated with a multidisciplinary approach.

Yosuke Kagawa1, Soichi Kitaguchi1, Hanae Konishi1, Kaori Hashimoto1, Osaki Norihito1, Tadashi Mizumoto1, Ryohei Nishino1, Fumihiro Sugahara1.   

Abstract

A 61-year-old woman was referred to our hospital due to right chest pain. A huge, 13-cm-diameter tumor was detected in the right lower lobe. For diagnostic and treatment purposes, pneumonectomy was performed, and the tumor was diagnosed as advanced pulmonary synovial sarcoma (SS) with pleural metastasis, according to immunohistochemistry analysis. Due to recurrence with brain metastases, treatment sequence composed of radiosurgery, doxorubicin, eribulin, and pazopanib was selected. The patient died after a considerably long survival of 29 months after the first visit. This case suggests that multimodal treatment may provide prolonged survival even for patients with advanced SS. © The Japan Society of Clinical Oncology 2020.

Entities:  

Keywords:  Doxorubicin; Eribulin; Multimodal therapy; Pazopanib; Radiosurgery; Synovial sarcoma

Year:  2020        PMID: 32257757      PMCID: PMC7109214          DOI: 10.1007/s13691-020-00399-2

Source DB:  PubMed          Journal:  Int Cancer Conf J        ISSN: 2192-3183


  17 in total

1.  Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial.

Authors:  Winette T A van der Graaf; Jean-Yves Blay; Sant P Chawla; Dong-Wan Kim; Binh Bui-Nguyen; Paolo G Casali; Patrick Schöffski; Massimo Aglietta; Arthur P Staddon; Yasuo Beppu; Axel Le Cesne; Hans Gelderblom; Ian R Judson; Nobuhito Araki; Monia Ouali; Sandrine Marreaud; Rachel Hodge; Mohammed R Dewji; Corneel Coens; George D Demetri; Christopher D Fletcher; Angelo Paolo Dei Tos; Peter Hohenberger
Journal:  Lancet       Date:  2012-05-16       Impact factor: 79.321

2.  TLE1 as a diagnostic immunohistochemical marker for synovial sarcoma emerging from gene expression profiling studies.

Authors:  Jefferson Terry; Tsuyoshi Saito; Subbaya Subramanian; Cindy Ruttan; Cristina R Antonescu; John R Goldblum; Erinn Downs-Kelly; Christopher L Corless; Brian P Rubin; Matt van de Rijn; Marc Ladanyi; Torsten O Nielsen
Journal:  Am J Surg Pathol       Date:  2007-02       Impact factor: 6.394

3.  A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma.

Authors:  Nabeel Pervaiz; Nigel Colterjohn; Forough Farrokhyar; Richard Tozer; Alvaro Figueredo; Michelle Ghert
Journal:  Cancer       Date:  2008-08-01       Impact factor: 6.860

Review 4.  Synovial sarcoma: defining features and diagnostic evolution.

Authors:  Khin Thway; Cyril Fisher
Journal:  Ann Diagn Pathol       Date:  2014-10-13       Impact factor: 2.090

5.  Trabectedin monotherapy after standard chemotherapy versus best supportive care in patients with advanced, translocation-related sarcoma: a randomised, open-label, phase 2 study.

Authors:  Akira Kawai; Nobuhito Araki; Hideshi Sugiura; Takafumi Ueda; Tsukasa Yonemoto; Mitsuru Takahashi; Hideo Morioka; Hiroaki Hiraga; Toru Hiruma; Toshiyuki Kunisada; Akihiko Matsumine; Takanori Tanase; Tadashi Hasegawa; Shunji Takahashi
Journal:  Lancet Oncol       Date:  2015-03-18       Impact factor: 41.316

6.  Statistics of soft-tissue sarcoma in Japan: Report from the Bone and Soft Tissue Tumor Registry in Japan.

Authors:  Koichi Ogura; Takahiro Higashi; Akira Kawai
Journal:  J Orthop Sci       Date:  2017-07       Impact factor: 1.601

7.  Salvage rates and prognostic factors after relapse in children and adolescents with initially localised synovial sarcoma.

Authors:  Andrea Ferrari; Gian Luca De Salvo; Patrizia Dall'Igna; Cristina Meazza; Francesco De Leonardis; Carla Manzitti; Maria Antonietta De Ioris; Michela Casanova; Modesto Carli; Gianni Bisogno
Journal:  Eur J Cancer       Date:  2012-07-24       Impact factor: 9.162

8.  Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics.

Authors:  Leona A Doyle; Marina Vivero; Christopher Dm Fletcher; Fredrik Mertens; Jason L Hornick
Journal:  Mod Pathol       Date:  2013-09-13       Impact factor: 7.842

9.  Lung cancer.

Authors:  W D Travis; L B Travis; S S Devesa
Journal:  Cancer       Date:  1995-01-01       Impact factor: 6.860

10.  Patterns of care and outcomes of patients with METAstatic soft tissue SARComa in a real-life setting: the METASARC observational study.

Authors:  Marion Savina; Axel Le Cesne; Jean-Yves Blay; Isabelle Ray-Coquard; Olivier Mir; Maud Toulmonde; Sophie Cousin; Philippe Terrier; Dominique Ranchere-Vince; Pierre Meeus; Eberhard Stoeckle; Charles Honoré; Paul Sargos; Marie-Pierre Sunyach; Cécile Le Péchoux; Antoine Giraud; Carine Bellera; François Le Loarer; Antoine Italiano
Journal:  BMC Med       Date:  2017-04-10       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.